retatrutide fda approval status november 2025 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. Adam Doctors prescribing weight loss drug

Muscle Preservation Weight-loss interventions often cause muscle loss

Starting at lower doses and titrating slowly remains the most reliable strategy for minimizing diarrhea and other side effects

The added glucagon receptor activation may enhance fat oxidation and increase energy expenditure beyond what dual agonists achieve

Lark can help you on your weight loss journey with GLP-1 medications as you manage side effects, get help taking your medications as prescribed, and establish healthy habits for lasting results

Tirzepatide is the active ingredient used in two products marketed by Eli Lilly: Mounjaro and Zepbound